-transparent.png){kind=logo}
T cell vaccination against experimental autoimmune disease is herein shown to be mediated in part by anti-ergotypic T cells, T cells that recognize and respond to the state of activation of other T cells. The anti-ergotypic response thus combines with the previously shown anti-idiotypic T cell response to regulate autoimmunity.
Related Publications
A W Lohse, and
F Mor, and
N Karin, and
I R Cohen
April 2007,
Annals of the New York Academy of Sciences,
A W Lohse, and
F Mor, and
N Karin, and
I R Cohen
November 2007,
Journal of neuroimmunology,
A W Lohse, and
F Mor, and
N Karin, and
I R Cohen
September 2013,
FASEB journal : official publication of the Federation of American Societies for Experimental Biology,
A W Lohse, and
F Mor, and
N Karin, and
I R Cohen
January 1992,
European journal of immunology,
A W Lohse, and
F Mor, and
N Karin, and
I R Cohen
January 2003,
Novartis Foundation symposium,
A W Lohse, and
F Mor, and
N Karin, and
I R Cohen
October 2010,
Clinical and experimental immunology,
A W Lohse, and
F Mor, and
N Karin, and
I R Cohen
July 1977,
Clinical and experimental immunology,
A W Lohse, and
F Mor, and
N Karin, and
I R Cohen
January 2011,
ISRN neurology,
A W Lohse, and
F Mor, and
N Karin, and
I R Cohen
August 2001,
Immunological investigations,
A W Lohse, and
F Mor, and
N Karin, and
I R Cohen
August 2013,
Journal of immunology (Baltimore, Md. : 1950),
